NEWCASTLE UPON TYNE, UK, July 9 (Korea Bizwire) – QuantuMDx Group Limited (‘QuantuMDx’ or the ‘Company’), a UK-based developer of transformational point-of-care diagnostics, today announces the launch of Q-POC™ – a rapid, PCR point of care diagnostic system. Launching at ECCMID 2021, QuantuMDx’s Q-POC™ system and its first test, a SARS-CoV-2 detection assay, are now CE-IVD marked [...]
NEWCASTLE UPON TYNE, UK, Dec. 22 (Korea Bizwire) – QuantuMDx Group Limited (“QuantuMDx”), a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today confirms its diagnostic assay for SARS-CoV-2 remains suitable for detecting all available virus strains, following the identification of a new strain of SARS-CoV-2. The UK COVID Genomics Consortium and Public Health [...]
NEWCASTLE UPON TYNE, UK, Dec. 17 (Korea Bizwire) – QuantuMDx Group Limited, a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today announced it is investing over £11 million to scale up production to mass manufacture its flagship diagnostic device, Q-POC™ and disposable test cassette. QuantuMDx accelerated development, scale-up and manufacture of Q-POC™ – [...]
NEWCASTLE UPON TYNE, UK/ CALIFORNIA, USA, Dec. 10 (Korea Bizwire) - QuantuMDx Group Limited and Ontera, Inc have announced a collaboration to create a next-generation solution for blood stream infection and drug resistance detection. The technology will be based on QuantuMDx’s rapid cell/sample preparation technology, Capture-XT® and Ontera’s powerful nanopore biosensor, currently utilized in their SAM [...]
Newcastle upon Tyne, UNITED KINGDOM, Apr. 17 (Korea Bizwire) – Quality control testing for autologous C>’s can be challenging as they are manufactured in small batches and personalised to each patient. However, the C> industry is accustomed to manufacturing therapies in large batches, for the treatment of tens of thousands of patients. Within this context, [...]